Immunophenotyping of Progenitor Cells
Corresponding Organization : Commissariat à l'Énergie Atomique et aux Énergies Alternatives
Other organizations : Centre Hospitalier Universitaire de Grenoble, Centre National de la Recherche Scientifique
Variable analysis
- Different phases of the cell cycle were observed after propidium iodide labeling.
- Evolution of progenitor cells upon amplification, as monitored by flow cytometry.
- Percentage of cells in different phases of the cell cycle, as determined by the Modfit LT v3.2 software.
- The flow cytometry was performed using a FACS Calibur (Beckton Dickinson, France) cytometer.
- Cells were labeled with specific antibodies: VioBlue-conjugated anti-CD34, phycoerythrin (PE)-conjugated anti-CD38, and a lineage mix of FITC-conjugated anti-CD3, CD19, CD56, CD13, CD14, and CD11a.
- For the differentiation assay, cells were labeled with Brilliant Violet-conjugated anti-CD34, FITC-conjugated anti-CD36, PE-conjugated anti-CD235a (GPA), and allophycocyanin (APC)-conjugated anti-CD71 antibodies.
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!